Together, the in vitro and in vivo evidence lead us to conclude that ICMT suppression in breast cancer cells creates a “BRCA-like” state, hence sensitizing them to PARP1 inhibitor–induced growth inhibition and apoptosis. The gene discussed is PARP1; the disease is breast cancer.